<DOC>
	<DOCNO>NCT00240318</DOCNO>
	<brief_summary>The purpose study see 40 mg rosuvastatin take daily reduce atherosclerosis ( fatty deposit ) artery</brief_summary>
	<brief_title>A Study To Evaluate Effect Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden ( ASTEROID )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Clinical indication coronary catheterization . Target Coronary Artery : The target vessel must .50 % reduction lumen diameter angiographic visual estimation throughout segment least 40 mm length ( target segment ) vessel must large enough accommodate IVUS catheter . A lesion 60 % permit distal target segment . Side branch target ( image ) vessel may narrow 70 % visual estimation , provide target segment contain lesion great 50 % . Use lipidlowering medication 3 month within previous 12 month . Longer period treatment permit potential effect therapy coronary atherosclerosis . Subjects receive treatment lipidlowering medication within past 4 week require 4week washout period follow baseline lipid profile take visit 2 . Clinically significant heart disease , opinion Principal Investigator ( designee ) , likely require coronary bypass surgery , cardiac transplantation , surgical repair and/or replacement course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Coronary Artery Disease</keyword>
</DOC>